Matthew Shields insider trades
Open-market stock purchases and sales by Matthew Shields, EVP, Global Operations at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Jun 3, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $322K |
| Jun 3, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $532K |
| Jun 3, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $548K |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
Companies traded
- TEVA Teva Pharmaceutical Industries Ltd: 4 sales, last Jun 18, 2026